CELL BIOTECH CO ., LTD
Cell Biotech ranks No.2 in Denmark's probiotics market and No.1 in Korean probiotics exports, selling its DUOLAC brand.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1995, Cell Biotech listed on KOSDAQ in 2002 and operates in probiotics, microbiome, and anticancer drug development. It sells lactic acid bacteria raw powder and finished products under its own brands DUOLAC and DUOLAB as well as OEM/ODM, domestically and abroad, while also developing 'Cellbiome', a personalized probiotics service, and a colorectal cancer treatment using a lactic-acid-bacteria drug delivery system. As of end-2025 it ranked No.2 in Denmark's probiotics market and No.1 in Korean probiotics exports, has sales agreements with related parties Cell Biotech International Co. and Cell Biotech International A/S, and holds an exclusive license for 3 patents and know-how from Yonsei University's Wonju Industry-Academic Cooperation Foundation.
Products & technology
- 원말
- DUOLAC
- DUOLAB
- 쎌바이옴
Clinical trials
data.go.kr1 MFDS clinical trial authorisations · 2024 (Phase 1 1)
- Phase 1PP-P8산2024-03-20
1 trial site
R&D and key agreements
Source: DART corporate disclosure유산균 약물전달체(DDS) 기반 대장암 치료제 · 대장암 · 임상 1상 시험 프로토콜 개발 · Phase 1 clinical trial protocol developed with C&R Research (2024-01-31); exclusive license for 3 patents and know-how from Yonsei University Wonju Industry-Academic Cooperation Foundation (2020-08-10)
GABA 생산용 기능성 유산균주(Y7균주) 대량배양·산업응용기술 · 기억력 개선 · 동물모델 효능 연구 · Efficacy of GABA-producing Y7 strain and mixed strains evaluated in animal models for memory improvement research
여성갱년기 개선용 고기능성 프로바이오틱스 혼합물(대두배아추출물 병용) · 여성 갱년기 증상 · 개별인정형 건강기능식품 개발 목표 · Efficacy of soy embryo extract (isoflavone, S30) combined with probiotics evaluated in menopause-induced animal models, with human trials planned
Companies in the same categoryPharma & CDMO
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition